AU631223B2 - Improved baculovirus expression vectors - Google Patents

Improved baculovirus expression vectors Download PDF

Info

Publication number
AU631223B2
AU631223B2 AU58207/90A AU5820790A AU631223B2 AU 631223 B2 AU631223 B2 AU 631223B2 AU 58207/90 A AU58207/90 A AU 58207/90A AU 5820790 A AU5820790 A AU 5820790A AU 631223 B2 AU631223 B2 AU 631223B2
Authority
AU
Australia
Prior art keywords
promoter
baculovirus
gene
modified
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU58207/90A
Other languages
English (en)
Other versions
AU5820790A (en
Inventor
Lois K. Miller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Original Assignee
University of Georgia Research Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Georgia Research Foundation Inc filed Critical University of Georgia Research Foundation Inc
Publication of AU5820790A publication Critical patent/AU5820790A/en
Application granted granted Critical
Publication of AU631223B2 publication Critical patent/AU631223B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C12N15/68—Stabilisation of the vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU58207/90A 1989-05-17 1990-05-17 Improved baculovirus expression vectors Ceased AU631223B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35384789A 1989-05-17 1989-05-17
US353847 1989-05-17

Publications (2)

Publication Number Publication Date
AU5820790A AU5820790A (en) 1990-12-18
AU631223B2 true AU631223B2 (en) 1992-11-19

Family

ID=23390826

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58207/90A Ceased AU631223B2 (en) 1989-05-17 1990-05-17 Improved baculovirus expression vectors

Country Status (5)

Country Link
EP (1) EP0426840A1 (fr)
JP (1) JPH04501065A (fr)
AU (1) AU631223B2 (fr)
CA (1) CA2033070A1 (fr)
WO (1) WO1990014428A1 (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106185D0 (en) * 1991-03-22 1991-05-08 Wellcome Found Biological control agents
US5593669A (en) * 1992-04-29 1997-01-14 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle
AU4117293A (en) * 1992-04-29 1993-11-29 Boyce Thompson Institute For Plant Research Inc. Oral infection of insect larvae with pre-occluded baculovirus particles
US6090379A (en) * 1992-04-29 2000-07-18 Boyce Thompson Institute For Plant Research, Inc. Stable pre-occluded virus particle for use in recombinant protein production and pesticides
FR2715664B1 (fr) * 1994-01-31 1996-04-12 Proteine Performance Sa Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
US6846481B1 (en) 1999-02-04 2005-01-25 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US7326568B2 (en) 1999-02-04 2008-02-05 University Of Georgia Research Foundation, Inc. Recombinant expression of heterologous nucleic acids in protozoa
US7026156B1 (en) 1999-02-04 2006-04-11 The University Of Georgia Research Foundation, Inc. Diagnostic and protective antigen gene sequences of ichthyophthirius
AU2005319099B2 (en) 2004-02-02 2010-09-16 Ambrx, Inc. Modified human growth hormone
CN103755800B (zh) 2004-02-02 2016-02-24 Ambrx公司 经修饰的人类生长激素多肽与其用途
CN102532321B (zh) 2004-06-18 2018-10-12 Ambrx公司 新颖抗原结合多肽和其用途
US7638299B2 (en) 2004-07-21 2009-12-29 Ambrx, Inc. Biosynthetic polypeptides utilizing non-naturally encoded amino acids
AU2005323106B2 (en) 2004-12-22 2010-07-29 Ambrx, Inc. Methods for expression and purification of recombinant human growth hormone
KR101224781B1 (ko) 2004-12-22 2013-01-21 암브룩스, 인코포레이티드 비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
US7385028B2 (en) 2004-12-22 2008-06-10 Ambrx, Inc Derivatization of non-natural amino acids and polypeptides
NZ555425A (en) 2004-12-22 2010-04-30 Ambrx Inc Compositions of aminoacyl-tRNA synthetase and uses thereof
WO2006133088A2 (fr) 2005-06-03 2006-12-14 Ambrx, Inc. Molecules d'interferons humains ameliorees et utilisations de celles-ci
CA2618878C (fr) 2005-08-18 2016-06-28 Ambrx, Inc. Compositions d'arnt et leurs utilisations
EP1951890A4 (fr) 2005-11-16 2009-06-24 Ambrx Inc Procedes et compositions comprenant des acides amines non naturels
WO2008030558A2 (fr) 2006-09-08 2008-03-13 Ambrx, Inc. Polypeptide plasmatique humain modifié ou squelettes de fc et leurs utilisations
PT2064333E (pt) 2006-09-08 2014-06-09 Ambrx Inc Supressor híbrido arnt para células de vertebrados
ES2457527T3 (es) 2006-09-08 2014-04-28 Ambrx, Inc. ARNt Supresor hibrido en células de vertebrados
KR101476472B1 (ko) 2007-03-30 2015-01-05 암브룩스, 인코포레이티드 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
KR20100019467A (ko) 2007-05-02 2010-02-18 암브룩스, 인코포레이티드 변형된 인터페론 베타 폴리펩티드 및 그의 용도
ES2632504T3 (es) 2007-11-20 2017-09-13 Ambrx, Inc. Polipéptidos de insulina modificados y sus usos
NZ602170A (en) 2008-02-08 2014-03-28 Ambrx Inc Modified leptin polypeptides and their uses
MX2011000859A (es) 2008-07-23 2011-02-24 Ambrx Inc Polipeptidos g-csf bovinos modificados y sus usos.
PL2342223T3 (pl) 2008-09-26 2017-09-29 Ambrx, Inc. Zmodyfikowane polipeptydy zwierzęcej erytropoetyny i ich zastosowania
NO2337846T3 (fr) 2008-09-26 2018-06-16
NZ600361A (en) 2009-12-21 2014-06-27 Ambrx Inc Modified bovine somatotropin polypeptides and their uses
EP2516455A4 (fr) 2009-12-21 2013-05-22 Ambrx Inc Polypeptides d'hormone de croissance porcine modifiée et leurs utilisations
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
SMT201900495T1 (it) 2010-08-17 2019-11-13 Ambrx Inc Polipeptidi di relaxina modificati e loro usi
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
BR112017008157A2 (pt) 2014-10-24 2017-12-19 Bristol Myers Squibb Co polipeptídeos de fgf-21 modificados e usos dos mesmos
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
CN116042720B (zh) * 2023-02-14 2025-09-02 中国科学院武汉病毒研究所 一种转运载体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3529189A (en) * 1988-05-31 1989-12-07 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes
AU5187190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Improved baculovirus expression system capable of producing foreign gene proteins at high levels

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3529189A (en) * 1988-05-31 1989-12-07 Centre National De La Recherche Scientifique (Cnrs) Modified baculovirus, method for preparing it and its use as an expression vector of genes
AU5187190A (en) * 1989-02-23 1990-09-26 University Of Ottawa Improved baculovirus expression system capable of producing foreign gene proteins at high levels

Also Published As

Publication number Publication date
CA2033070A1 (fr) 1990-11-18
AU5820790A (en) 1990-12-18
EP0426840A1 (fr) 1991-05-15
JPH04501065A (ja) 1992-02-27
WO1990014428A1 (fr) 1990-11-29

Similar Documents

Publication Publication Date Title
US5244805A (en) Baculovirus expression vectors
AU5820790A (en) Improved baculovirus expression vectors
EP0549721B1 (fr) Systeme d'expression de baculovirus a promoteurs multiples et production de particules defectives
Tessier et al. Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide
US5194376A (en) Baculovirus expression system capable of producing foreign gene proteins at high levels
US5516657A (en) Baculovirus vectors for expression of secretory and membrane-bound proteins
US4745051A (en) Method for producing a recombinant baculovirus expression vector
JP3183877B2 (ja) 修飾バキュロウイルス、その調整方法及びそれの形質発現ベクターとしての適用
US4879236A (en) Method for producing a recombinant baculovirus expression vector
US5518913A (en) High level recombinant protein production using conditional helper-free adenovirus vector
US5278050A (en) Method to improve the efficiency of processing and secretion of foreign genes in insect systems
US6090584A (en) Baculovirus artificial chromosomes and methods of use
NO173944B (no) Fremgangsmaate for fremstilling av en rekombinant baculovirus-ekspresjonsvektor
US5322774A (en) Procaryotic leader sequence in recombinant baculovirus expression system
EP0397485A1 (fr) Vecteurs d'expression de baculovirus et leur utilisation pour l'expression de protéines étrangères dans des insectes ou cellules d'insectes
EP0228036A2 (fr) Méthode de production de polypeptides sélectionnés dans des cellules d'insectes infectées par des virus et polypeptides ainsi isolés
Beljelarskaya A baculovirus expression system for insect cells
AU684799B2 (en) Gene insertion by direct ligation (in vitro)
US6037150A (en) Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells
WO1998050571A1 (fr) Vecteur d'administration de gene a base d'entomopoxvirus pour vertebres
CA1330425C (fr) Systeme d'expression dans baculovirus permettant de produire des proteines etrangeres en grande quantite
CN118291542A (zh) 多基因缺失的高产杆状病毒表达载体Bac5.0s及其应用
Heldens et al. Generation of a p10-based baculovirus expression vector in yeast with infectivity for insect larvae and insect cells
Smith et al. Method for producing a recombinant baculovirus expression vector
Hong et al. Comparison of promoter activity of the p10 gene between Bombyx mori nucleopolyhedrovirus variants